NCT06299631View on ClinicalTrials.gov

Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease

CompletedOBSERVATIONAL
Enrollment

133

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2023

Study Completion Date

December 31, 2023

Conditions
Crohn's Disease
Interventions
PROCEDURE

Ileocolic resection

Ileocolic resection by open or laparoscopic approach

Trial Locations (1)

34295

Montpellier University Hospital, Montpellier

All Listed Sponsors
collaborator

Carémeau University Hospital, Nîmes

UNKNOWN

lead

University Hospital, Montpellier

OTHER

NCT06299631 - Endoscopic Relapse Risks Evaluation After Ileocolic Resection for Crohn's Disease | Biotech Hunter | Biotech Hunter